4

LEDERMAN - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Company: Tonix Pharmaceuticals Holding Corp.
Filed: May 15, 2025
Period of Report: May 15, 2025
Accession Number: 0001999371-25-006261

View Document ↗ View on SEC.gov ↗